Peter Gerhardsson

Biography

For more than thirty years Peter has worked within the pharmaceutical and medical technology business sector. He has extensive experience with diabetes therapies. From 1980 to 2000 he held various sales and marketing roles for Novo Nordisk, including several senior management positions. From 1991 through 1993, Peter led the Far East business for Novo Nordisk, managing its fast-growing presence in China, India, South Korea and the Southeast Asian countries. From 1994 - 2000, he was the Managing Director of the Swedish affiliate. After joining MiniMed in 2000, Peter was responsible for operations in the Nordic countries, and later was responsible for all European diabetes business units with Medtronic. In 2005, he rejoined Novo Nordisk as Corporate Vice President of Corporate Responsibility, including Socio Economics, Stakeholder relations and Social Responsibility programs. Since 2008 he has been with Dexcom as Vice President International Business Development. During these years a global network of distributors for the company´s Continuous Glucose Monitoring (CGM) system has been established with highly significant revenue and market access. Since January 2017 Peter heads the market and business development of the Emerging Markets for Dexcom.

Research Interest

 Peter main research interest in Diabetes and Endocrinology therapies.